Rheumatoid Arthritis Clinical Trials

Showing 15301-15320 of 47,334 trials

Blood Ropivacaine Concentrations Following Chest Wall Nerve Block Continuous Infusion

NCT02860091

The main objective of this proposed investigation is to evaluate blood ropivacaine concentrations in infants and toddlers following the initiation of, and over the course of, continuous paravertebral nerve blockade using ropivacaine infusion for postoperative pain control following esophageal atresia repair procedures that include posterior tracheopexy. Continuous unilateral chest wall nerve blockade (CUCWNB) using ropivacaine is the current standard of practice for this surgical population at the investigators' institution and, as such, this study does not aim to alter the current standard clinical care received by participants but rather evaluate the blood concentrations of ropivacaine as it is routinely used.

Pain, Postoperative

Boston Children's Hospital26 participantsStarted Oct 2018

Boston, Massachusetts, United States

Not Yet RecruitingPhase 2

The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy

NCT06614985

This is a multiple-center, prospective, open-label, positive drug controlled, randomized, clinical study to evaluate the safety and efficacy of Telitacicept in the treatment of primary membranous nephropathy.

Primary Membranous Nephropathy

Renmin Hospital of Wuhan University172 participantsStarted Oct 2024

Wuhan, Hubei China, China

Not Yet Recruiting

Cardiovascular Manifestations in Ph-negative MPN

NCT06615414

The primary aim of this research is to investigate the clinical and subclinical cardiovascular complications and its relationship with myeloproliferative neoplasms seeking to assess incidence, prevalence and severity in comparison to healthy group and analyze potential risk factors including genetic mutations, inflammatory markers and hematological parameters

Philadelphia Negative Myeloproliferative Neoplasms

Assiut University80 participantsStarted Oct 2024

Blood Ropivacaine Concentrations Following Chest Wall Nerve Block Continuous Infusion

The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy

Cardiovascular Manifestations in Ph-negative MPN

Related Searches

Study of the Associations Between Subchondral Insufficiency Fractures of the Knee and Pre-existing Health, Lifestyle, and/or Musculoskeletal Conditions

Effectiveness of the AI-Supporter in Reducing Urinary Tract Infections

Frailty, Hip Fractures and Inflammatory Biomarkers

The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry

Super-Hypofractionated Partial Breast Irradiation

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.

Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma

Remote Ischemic Conditioning in Oncology

REduced Pain After Bariatric Surgery - Gastric Bypass

PK of Piperacillin/Tazobactam in Adults Undergoing ECMO

Biological Parameters Changes After Autologous Blood Transfusion of Red Blood Cells (200 Ml) in Healthy Volunteers.

Mimic Muscle Volume, Central Facial Palsy Severity and Dysphagia

A Study of Enlicitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Participants With Moderate Renal Impairment (MK-0616-007)

Renoir: A Randomised, Double-blind, Controlled Trial to Evaluate the Effects of a New Human Milk Fortifier on Growth and Tolerance in Preterm Infants.

Effect of PEEP on TRJV in Mechanically Intubated Pediatric Patients

Serum Calprotectin in Surgical Septic Patients